First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Unmet Needs in HR-Positive Metastatic Breast Cancer

Peer Exchange

CDK4/6 Inhibition's Role in HR+ Metastatic Breast Cancer

Selecting Agents in CDK4/6 Inhibition for HR+ mBC

HR+ mBC: Factors in Selecting CDK4/6 Inhibitions

HR+ mBC: Treatment After Progression on CDK4/6 Inhibition

Do CDK4/6 Inhibitors Impact Later Therapy in HR+ mBC?

PI3K and PARP Inhibitors in HR+ Metastatic Breast Cancer

Developments in Chemotherapy for HR+ mBC

Optimizing Selection of Chemotherapy for HR+ mBC

Tesetaxel: An Oral Taxane for HR+ mBC

HR+ mBC: Considering the Data and Potential of Tesetaxel

Tesetaxel in Doublet Therapy for HR+ mBC

HR+ mBC: Oral Formulations of Docetaxel and Paclitaxel